Recent News

• 05.29.2026 - Aptose Biosciences Announces Update on Anticipated Timing of Closing of the Plan of Arrangement with Hanmi Pharmaceutical
• 05.29.2026 - Aptose Biosciences Announces Update on Anticipated Timing of Closing of the Plan of Arrangement with Hanmi Pharmaceutical
• 05.13.2026 - Aptose Reports First Quarter 2026 Results
• 05.13.2026 - Aptose Reports First Quarter 2026 Results
• 04.30.2026 - Aptose Biosciences Announces Update on Anticipated Timing of Closing of the Plan of Arrangement with Hanmi Pharmaceutical
• 04.30.2026 - Aptose Biosciences Announces Update on Anticipated Timing of Closing of the Plan of Arrangement with Hanmi Pharmaceutical
• 03.31.2026 - Aptose Biosciences Announces Results of Special Shareholders Meeting; Announces Receipt of Final Court Approval of Plan of Arrangement; Reports Year End 2025 Results and Corporate Highlights
• 03.31.2026 - Aptose Biosciences Announces Results of Special Shareholders Meeting; Announces Receipt of Final Court Approval of Plan of Arrangement; Reports Year End 2025 Results and Corporate Highlights

Recent Filings

• 05.29.2026 - EX-99.1 EX-99.1
• 05.29.2026 - 8-K Current report
• 05.13.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.13.2026 - 8-K Current report
• 05.13.2026 - EX-99.1 EX-99.1
• 04.30.2026 - EX-99.1 EX-99.1
• 04.30.2026 - 8-K Current report
• 04.01.2026 - SC 13E3/A Going private transaction by certain issuers
• 03.31.2026 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.31.2026 - 8-K Current report